Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC.
Cancers (Basel). 2022 Jul 8;14(14):3332. doi: 10.3390/cancers14143332.
Cancers (Basel). 2022.
PMID: 35884392
Free PMC article.
Review.